Vitamin K-Antagonist: An Illegal Means to Terminate Pregnancy?

被引:0
|
作者
Cupisti, S. [1 ]
Cupisti, D. [1 ]
Schwarze, B.
Ringwald, J. [2 ]
Schroth, M. [3 ]
Beckmann, M. W. [1 ]
Goecke, T. W. [1 ]
机构
[1] Univ Klinikums Erlangen, Frauenklin, Erlangen, Germany
[2] Transfus Med Univ Erlangen, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Kinder & Jugendklin, Erlangen, Germany
关键词
vitamin K-antagonist; termination of pregnancy; 218; ANTICOAGULATION;
D O I
10.1055/s-0030-1250676
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: In Germany the number of terminations of pregnancies including not officially reported terminations is estimated to run to more than 200000 annually. Both surgical procedures and medications are used to legally terminate pregnancies. It is assumed that these procedures are also used for illegal terminations. Historically, the use of many different procedures has been reported. To date, however, therewere no reports of the illegal use of other ordinary medications to terminate pregnancy. Methods: Severe intoxication with a vitamin K-antagonist during pregnancy has been reported in two cases. The current legal and historical means of terminating pregnancy and the associated complications are presented here. Results: After excluding other reasons it must be assumed that in both cases either the pregnant patient herself or another person was responsible for the intoxication with the aim of terminating the pregnancy. In view of the historical precedents, intoxication with a vitamin K-antagonist with the intention of terminating a pregnancy appears to offer a new illegal means of termination, using a medication developed for a completely different purpose and which may, moreover, result in many complications. Conclusion: Physicians should be aware of this possibility as a rare differential diagnosis in special cases.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [41] Non-Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement
    Alaour, Bashir
    Ferrari, Enrico
    Heg, Dik
    Tueller, David
    Pilgrim, Thomas
    Muller, Olivier
    Noble, Stephane
    Jeger, Raban
    Reuthebuch, Oliver
    Toggweiler, Stefan
    Templin, Christian
    Wenaweser, Peter
    Nietlispach, Fabian
    Taramasso, Maurizio
    Huber, Christoph
    Rof, Marco
    Windecker, Stephan
    Stortecky, Stefan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (03) : 405 - 418
  • [42] Vitamin K antagonist use in the elderly: special considerations
    Siguret, Virginie
    Pautas, Eric
    Gouin-Thibault, Isabelle
    FUTURE CARDIOLOGY, 2007, 3 (03) : 321 - 330
  • [43] The effect of subclinical hypothyroidism on vitamin K antagonist treatment
    Squizzato, Alessandro
    Galli, Luca
    van Zaane, Bregje
    Romualdi, Erica
    Stuijver, Danka J.
    Dentali, Francesco
    Ageno, Walter
    Gerdes, Victor E. A.
    THROMBOSIS RESEARCH, 2012, 129 (04) : 520 - 522
  • [44] CURRENT PRACTICE WITH VITAMIN-K ANTAGONIST THERAPY
    KAZMIER, FJ
    MAYO CLINIC PROCEEDINGS, 1974, 49 (12) : 918 - 922
  • [46] Flaccid spontaneous paraplegia related to vitamin K antagonist
    Soufiani, Aida
    Ismaili, Nabila
    Bendagha, Nesma
    Mossadak, Ahlam
    Faroudy, Mamoune
    Sbihi, Ahmed
    PRESSE MEDICALE, 2010, 39 (09): : 1002 - 1005
  • [47] Vitamin K antagonist control in Eastern and Southeastern Asia
    Oh, S.
    Goto, S.
    Angchaisuksiri, P.
    Camm, A. J.
    Cools, F.
    Haas, S.
    Koretsune, Y.
    Lim, T. W.
    Accetta, G.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 544 - 544
  • [48] Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome
    Leong, Derek
    Wu, Peter E.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 509 - 510
  • [49] Persistence of vitamin K antagonist therapy in the real world
    Simonyi, G.
    Molnar, M. P.
    EUROPEAN HEART JOURNAL, 2014, 35 : 726 - 727
  • [50] Vitamin K antagonist-associated microscopic hematuria
    Shabaka, Amir
    Cases-Corona, Clara
    Larrea, Emily
    Arribalzaga, Karmele
    Alonso, Carmen Herrero
    Sanz, Juan Manuel Acedo
    Fernandez-Juarez, Gema
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (06): : 724 - 728